Abstract

MYC and MiR: vicious circle

Highlights

  • Increasing evidence suggests that a dynamic interaction occurs between the lymphoma cell and its microenvironment (TME, stroma), with each profoundly influencing the behavior of the other

  • When applied these models to determine the functional role of miRNAs and miRNA-regulated proteins in TME-mediated drug resistance and lymphoma progression, a global miRNA expression profiling was performed and revealed that expression of multiple miRNAs is altered in lymphoma cells upon adhesion to HK cells [4]

  • Given that MYC overexpression promotes lymphoma progression by inducing proliferation and makes the lymphoma cells prone to apoptosis, a concomitant stroma-activated pro-survival signal pathway is essential to cooperate with MYC in lymphoma TME to confer lymphoma cell survival advantage, drug resistance and proliferation potential

Read more

Summary

Introduction

Increasing evidence suggests that a dynamic interaction occurs between the lymphoma cell and its microenvironment (TME, stroma), with each profoundly influencing the behavior of the other. When applied these models to determine the functional role of miRNAs and miRNA-regulated proteins in TME-mediated drug resistance and lymphoma progression, a global miRNA expression profiling was performed and revealed that expression of multiple miRNAs is altered in lymphoma cells upon adhesion to HK cells [4].

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.